uniQure N.V. (QURE) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

83% of 6 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
goedbegingoedbegin goedbegingoedbegin 04/14/2015 1 Year $29.76 $26.62 -10.55% -10 Active
Comments: undervalued
Netteligent Netteligent 04/09/2015 1 month $30.81 $26.62 -13.61% 13 Active
Comments:
ashu210890 ashu210890 04/08/2015 1 month $33.16 $26.62 -19.72% -19 Active
Comments:
Work Smarter Not Harder Work Smarter Not Harder 03/20/2015 1 Year $27.55 $26.62 -3.38% -3 Active
Comments: Price for a treatment, company is undervalued
MLL MLL 02/12/2015 1 Year $19.49 $26.62 +36.58% 36 Active
Comments: undervalued
just profit just profit 01/15/2015 1 Year $20.32 $26.62 +31% 31 Active
Comments: First gene therapy drug Glybera on the market by UniQure!

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.